Latest Alzinova News & Updates
See the latest news and media coverage for Alzinova. We track all announcements, press releases, and industry mentions in real time, all in one place.
Clinical-stage biopharma developing Alzheimer's immunotherapy
alzinova.com- Headquarters
- Gothenburg, Sweden
- Founded year
- 2011
- Company type
- Public company
- Number of employees
- 5–10
Last updated
Latest news about Alzinova
In short: Alzinova secured financing and advanced its ALZ-101 Alzheimer's vaccine toward Phase II trials following positive clinical data and FDA Fast Track.
Company announcements
-
Alzinova executes plan with strengthened position
Progress includes validated Phase Ib data, FDA Fast Track status, IND approval, and path to global Phase II study with ALZ-101. CEO shares insights in new Q&A.
-
Alzinova gears up for Phase II with secured financing
New CEO discusses preparations in Biostock interview. Date is 2026-03-05.
-
Alzinova’s management discusses rights issue and Phase II study
CEO and CFO explain SEK 50 million rights issue to strengthen finances for ALZ-101 preparations.
-
Alzinova’s CEO presents path forward
He discusses Phase II preparations for ALZ-101 and ongoing rights issue to fund CMC and regulatory work.
Media coverage
-
Alzinova, Amsterdam UMC to Develop Blood-Based Alzheimer's Diagnostic Assay
The collaboration aims to develop a blood-based test that measures naturally occurring antibodies against toxic amyloid‑β oligomers in healthy individuals.
-
Alzinova publishes year-end report 2025 — TradingView News
The Board of Directors and the Chief Executive Officer of Alzinova AB hereby present the year-end report for the period January – December, and the...
-
Alzinova AB: Alzinova's Board of Directors resolves on a directed issue of units to underwriters in connection with the completed rights issue
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, JAPAN, NEW ZEALAND, SOUTH...
-
Alzinova announces final outcome of the rights issue
Alzinova AB (publ) ("Alzinova" or the "Company") hereby announces the final outcome of the rights issue of units, consisting of shares and warrants of series...
Track Alzinova and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Alzinova competitors & trending companies
Browse news for competitors to Alzinova and other trending companies.
BioArctic
Origami Therapeutics
Herantis Pharma
Pit
Davis AI
Qutwo
DigiPowerX
Penguin Solutions
Sterling Infrastructure
KIOXIA Corporation
Subquadratic
Tibber
IREN
A24
Hitachi Energy
Ouster
Ormat Technologies
Fabrinet
AOI
WidePoint
Filtronic
Mirum Pharmaceuticals
Capstone Green Energy
AXT
POET Technologies
PurpleFire
Profitable Media
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable